After a big rally in January to begin the year, the Global Cannabis Stock Index lost 6.3% in February to 10.02: After falling 23.7% in Q3 and 13.8% in Q4, which were...
After breaking a long negative streak in July of 17 straight months down and then a rally of 4.3%, the Global Cannabis Stock Index fell 1.3% in August. In September, it...
You’re reading a copy of this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight to...
Exclusive Interview with 22nd Century Group CEO Jim Mish 22nd Century Group (NASDAQ: XXII) is a plant-based biotechnology that operates three business segments: tobacco, cannabis/hemp and hops. The company...
The Global Cannabis Stock Index posted a gain for the first time in 17 months, rising 4.3% in July. In August, it retreated slightly, falling 1.3% to 15.20. After a 26% decline...
The Global Cannabis Stock Index posted a gain for the first time in 17 months, rising 4.3% in July. It closed up from 14.76, the lowest close ever, on 6/30...
You’re reading a copy of this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight to...
BUFFALO, N.Y., July 21, 2022 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (Nasdaq: XXII), leading agricultural biotechnology company dedicated to improving human health with reduced nicotine tobacco, hemp/cannabis, and...
The Global Cannabis Stock Index was beaten up in June, its 16th consecutive monthly decline. It closed at the lowest close ever as the index fell 23.1% to 14.76. The...
The Global Cannabis Stock Index fell for the tenth consecutive month, declining 11.5% to 32.85: The index, which was down 21.2% in Q3, had 42 qualifying members during the month and was...
The Global Cannabis Stock Index fell for the fifth consecutive month, declining 7.8% to 52.67: The index, which was down 8.7% during Q2, had 44 qualifying members during the month following the...
Exactus Joins with Panacea Life Sciences to Create Premier CBD Wellness Platform Leslie Buttorff, Founder of Panacea, To Lead Combined Companies as Chief Executive Officer DELRAY BEACH, FL /...
22nd Century Announces $40 Million Common Stock Registered Direct Offering Financing Provides Support to the Company’s Strategic Objectives Across All Its Plant Franchises BUFFALO, N.Y., June 07, 2021 (GLOBE...
The Global Cannabis Stock Index shook off a mid-month meltdown but still fell for the second consecutive month, declining 2.2% to 61.19: The index, which had 48 qualifying members during the...
After a sharp decline in September that left the index down 7% in Q3, the Global Cannabis Stock Index held on to massive gains in October and November, decreasing 0.8% to...
The Global Cannabis Stock Index gave up all of its gains from July and August to end Q3 down 6.7%, decreasing 16.2% in September to 27.45: The index, which had 37...
Overcoming pressure on Canadian LPs and CBD companies with very strong performance from American cannabis operators, the Global Cannabis Stock Index extended July gains during August by increasing 2.1% in choppy...
Cannabis stocks accelerated their rally in May, with the Global Cannabis Stock Index gaining 27.0% to 32.52: The index, which had 35 qualifying members during the month following the quarterly rebalancing...
Already down sharply through February, the Global Cannabis Stock Index extended its losses with a 24.9% decline during March, ending at 23.58 despite a bounce from record lows mid-month: The index,...
22nd Century Group Enters CBD Health and Wellness Market with Investment in Panacea Life Sciences, Inc. Investment provides platform to commercialize 22nd Century’s unique hemp/cannabis plant lines in development...
After beginning the year with a 57.4% gain in Q1, the Global Cannabis Stock Index moved sharply lower again in November, its eighth consecutive monthly decline, as it lost 12.0% to...
After a 57.4% gain in Q1 followed by a pullback that had left it down 1% year-to-date as of the end of August, the Global Cannabis Stock Index moved sharply lower...
After a 57.4% gain in Q1 followed by a 28.0% pullback in Q2 and 13.8% decline in July, Cannabis stocks, as measured by the Global Cannabis Stock Index, moved sharply...
After a 57.4% rebound in Q1, Cannabis stocks, as measured by the Global Cannabis Stock Index, gave up some ground in April, declining 1.5%: The index, which had 64 qualifying...
Cannabis stocks, as measured by the Global Cannabis Stock Index, extended their 2019 gains in March, increasing 2.2% to 100.76, leaving the index up 57.4% so far this year: The...
